In this regard, the adenosine generating ectoenzymes CD39 (61, 62) and CD73 (62) as well as the A2AR (63) have been proposed as immune checkpoints and expression of these molecules in tumor tissue has been correlated with poor prognosis (64). The gene discussed is ADORA2A; the disease is neoplasm.